Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (19262)	3/31/2004 8:39:49 AM
From: rrufff	Read Replies (1) \| Respond to of 120405

CTE -cardio bypass reports major progress today. CardioTech International Reports Update on Coronary Artery Bypass Graft Clinical Trials: Three Adult Patients Have Now Reached Critical Six Months Milestone PR Newswire - March 31, 2004 08:30 WILMINGTON, Mass., Mar 31, 2004 /PRNewswire-FirstCall via COMTEX/ -- CardioTech International, Inc. (Amex: CTE) today announced that the first three adult patients enrolled in the Brazilian clinical trials have reached the six months milestone. All three patients implanted with CardioTech's coronary artery bypass graft (CABG) are alive and living normal lives. All the patients were "no-option, re-do" patients; in other words, patients who had used all available veins in their body in previous coronary bypass surgeries. All of the patients were also diabetic (diabetes is a major contributing factor to coronary artery disease). The longest living patient with the CardioPass synthetic coronary artery bypass graft was implanted on August 6, 2003 and has been living a normal live for seven months and three weeks. Historical clinical data suggests that the majority of clinical problems are encountered in the first six months after implantation of a coronary graft. Michael Szycher, Ph.D., CEO of CardioTech International, Inc., stated: "In order to keep our investors informed on the progress of our clinical trial in Brazil, I am happy to report that the first three patients are doing well, at home and undergoing routine periodic hospital tests. The graft is performing as designed. In order to comply with all applicable regulations designed to prevent marketing of an unapproved medical device, we cannot provide detailed clinical data at this time." Dr. Szycher continued: "We are happy that we are not just prolonging life, but are providing our patients with a good quality of life. A good quality of life encompasses the overall well-being of the patients, their mental state and freedom from chest pain (angina)." About CardioTech: CardioTech International, Inc. delivers innovative solutions and quality products primarily focused on the treatment of cardiovascular disease. CardioTech is comprised of a unique combination of established devices and products, augmented with significant product development activities, with operations in Wilmington, Massachusetts, Plymouth, Minnesota and Rancho Santa Margarita, California. Current revenue sources for CardioTech include patented medical grade polyurethanes for use in implantable medical devices, disposable devices manufactured on an OEM basis for Fortune 100 companies, cardiovascular tubing systems, arterial filters, oxygenators, cardioplegia delivery systems and oxygen saturation monitors. CardioTech's hydrogel and alginate wound dressings address a combined $600 million annual market. CardioTech is also developing a synthetic coronary artery bypass graft that addresses a potential market of $1.5 billion annually. Additionally, CardioTech has partnered with Implant Sciences and CorNova to accelerate the development of a drug-eluting stent that addresses a $1 billion market. CardioTech believes that this Release contains forward-looking statements that are subject to risks and uncertainties. Such statements are based on management's current expectations and are subject to clinical trials results that could cause results to differ materially from the forward-looking statements. Please refer to CardioTech's SEC filings. For more information, please contact: Dave Gentry Investor Relations Specialist Aurelius Consulting Group 407-644-4256 Dave@aurcg.com www.runonideas.com SOURCE CardioTech International, Inc.

To: GARY P GROBBEL who wrote (19262)	3/31/2004 10:33:31 AM
From: GARY P GROBBEL	Read Replies (3) \| Respond to of 120405

RPMM .51 up .11...i will post more on this in a little bit but right now it is moving higher on 43,000 vol...note last para ref $10m rev for this year...last year was $1.5m rev: RPM Technologies, Inc. Develops Innovative New Pallet Design Tuesday March 30, 1:14 pm ET PLAINFIELD, Ill., March 30, 2004 (PRIMEZONE) -- The following information is being issued by RPM Technologies, Inc. (OTC BB:RPMM.OB - News): ADVERTISEMENT Industry demand for plastic pallets continues to escalate as major US shippers switch from wood to plastic. Exporters are leading the changeover due to restrictions made by 90 foreign countries banning the use of untreated wood packaging and shipping materials. Higher cost of plastic versus wood is now offset by the cost to treat or coat a wood pallet. RPM's export pallet, made from recycled resins, is actually less expensive than a wood pallet that has to be treated. Plastic is easier to store and transport; and, worker injuries due to splintering and gouging are virtually eliminated. Unlike wood, plastic is easy to clean. It's impervious to contamination and is consistent in weight and size. One of the major complaints about plastic pallets, however, is that they're slippery. Boxes can slide causing load imbalance and possible product damage. Some plastic pallet manufacturers have provided varieties of surface textures to retard slippage. Unfortunately, they haven't worked to the satisfaction of most shippers. Even when a plastic pallet's surface has been scuffed or abraded, loads will slide and shift. That was before RPM's innovative new pallet technology was developed. The new pallet will go into production until 3rd quarter 2004 and its creators have guaranteed that it will eliminate virtually any kind of slippage. The soon-to-be patented process entails the use of alternative materials imbued into selected surface areas. These non-slip pallets will be available in several sizes and configurations. The Company plans to make industry-wide announcements of the pallet's features and low cost this summer. While the shipper's primary concern is function and price, it's also nice to know that buying plastic pallets aids the environment. Wood pallets are an environmental menace. They consume 40% of US hardwood supply and accelerate landfill volume. They deplete forests and present a serious disposal problem for many communities. Additionally, wood pallets have been identified as harboring vermin, bacteria and insects. The company estimates sales will continue to accelerate to the $10 million level this year and higher in 2005. RPM trades on the OTCBB. Their trading symbol is RPMM. Visit the Company's website at ``http://www.rpmplasticpallets.com''.